"China's engagement in African health has shifted from short-term aid missions towards more complex, long-term collaborative projects, including building joint hospitals and medical centres."
"Chinese company Shanghai Fosun Pharmaceutical is developing a €50 million facility in Côte d'Ivoire to produce antimalarial and antibacterial medicines, enhancing local pharmaceutical capabilities."
"At the 2024 Summit of the Forum on China-Africa Cooperation, President Xi Jinping emphasized the importance of joint modernization between China and Africa, stating that without their modernization, there will be no global modernization."
"The deepened commitment to Africa coincides with a sharp decline in US support for aid programmes, with 83% of USAID's programmes set to be cancelled, impacting health initiatives."
Since 2017, China's Health Silk Road initiative has transformed its health engagement in Africa from short-term aid to long-term collaborations. This includes building hospitals, enhancing healthcare services, and investing in pharmaceutical production. Chinese companies are establishing facilities for medicine production in various African countries. At the 2024 FOCAC summit, President Xi Jinping reaffirmed China's commitment to modernization in partnership with Africa. This increased involvement comes as US support for health aid in Africa declines significantly, with major cuts announced by USAID.
Read at Nature
Unable to calculate read time
Collection
[
|
...
]